CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.
Pampusch MS, Abdelaal HM, Cartwright EK, Molden JS, Davey BC, Sauve JD, Sevcik EN, Rendahl AK, Rakasz EG, Connick E, Berger EA, Skinner PJ.
Pampusch MS, et al. Among authors: rendahl ak.
PLoS Pathog. 2022 Feb 7;18(2):e1009831. doi: 10.1371/journal.ppat.1009831. eCollection 2022 Feb.
PLoS Pathog. 2022.
PMID: 35130312
Free PMC article.